All Stories

  1. The worldwide epilepsy treatment gap: A systematic review and recommendations for revised definitions – A report from the ILAE Epidemiology Commission
  2. Thirty-day readmission after status epilepticus in the United States: Insights from the nationwide readmission database
  3. Big data in epilepsy: Clinical and research considerations. Report from the Epilepsy Big Data Task Force of the International League Against Epilepsy
  4. Author response: Assessment and effect of a gap between new-onset epilepsy diagnosis and treatment in the US
  5. New-onset lesional and nonlesional epilepsy in the US population: Patient characteristics and patterns of antiepileptic drug use
  6. Antiepileptic Drug Treatment Patterns in Women of Childbearing Age With Epilepsy
  7. Assessment and effect of a gap between new-onset epilepsy diagnosis and treatment in the US
  8. Independent role of neonatal seizures in subsequent neurological outcomes: a population‐based study
  9. Epidemiology of traumatic brain injury-associated epilepsy and early use of anti-epilepsy drugs: An analysis of insurance claims data, 2004–2014
  10. Patient characteristics and treatment patterns in patients with newly diagnosed epilepsy: A US database analysis
  11. The primary prevention of epilepsy: A report of the Prevention Task Force of the International League Against Epilepsy
  12. National Association of Medical Examiners Position Paper: Recommendations for the Investigation and Certification of Deaths in People with Epilepsy
  13. National Association of Medical Examiners position paper: Recommendations for the investigation and certification of deaths in people with epilepsy
  14. Comorbidities and risk factors associated with newly diagnosed epilepsy in the U.S. pediatric population
  15. Premature mortality of epilepsy in low- and middle-income countries: A systematic review from the Mortality Task Force of the International League Against Epilepsy
  16. Omega-3 fatty acids and SUDEP prevention – Authors’ reply
  17. The burden of premature mortality of epilepsy in high-income countries: A systematic review from the Mortality Task Force of the International League Against Epilepsy
  18. Epilepsy or seizure disorder? The effect of cultural and socioeconomic factors on self-reported prevalence
  19. Sudden unexpected death in epilepsy: epidemiology, mechanisms, and prevention
  20. Health-care access among adults with epilepsy: The U.S. National Health Interview Survey, 2010 and 2013
  21. Estimating Epilepsy Incidence and Prevalence in the US Pediatric Population Using Nationwide Health Insurance Claims Data
  22. Recognizing and preventing epilepsy-related mortality
  23. Prevalence of pediatric epilepsy in low-income rural Midwestern counties
  24. Descriptive epidemiology of epilepsy in the U.S. population: A different approach
  25. Newer antiepileptic drug use and other factors decreasing hospital encounters
  26. The Epidemiology of Traumatic Brain Injury in Children and Youths
  27. Sudden unexpected death in epilepsy: Assessing the public health burden
  28. Prevalence of epilepsy in rural Kansas
  29. The prevalence of epilepsy along the Arizona–Mexico border
  30. Valproate prescriptions for nonepilepsy disorders in reproductive-age women
  31. Association of statin use with peripheral neuropathy in the US population 40 years of age or older (美国40岁及以上人群的他汀使用情况与周围神经病变的关系)
  32. Summary of evidence-based guideline update: Evaluation and management of concussion in sports: Report of the Guideline Development Subcommittee of the American Academy of Neurology
  33. Racial and socioeconomic disparities in epilepsy in the District of Columbia
  34. Validation of self-reported epilepsy for purposes of community surveillance
  35. Surveillance of Traumatic Brain Injury
  36. Standards for epidemiologic studies and surveillance of epilepsy
  37. Associates of stigma in an incident epilepsy population from northern Manhattan, New York City
  38. Effect of Exercise on Cognitive Performance in Community-Dwelling Older Adults: Review of Intervention Trials and Recommendations for Public Health Practice and Research
  39. Adverse antiepileptic drug effects in new-onset seizures: A case-control study
  40. Unmet Health Care Needs Among CSHCN With Neurologic Conditions
  41. A population-based study of risk of epilepsy after hospitalization for traumatic brain injury
  42. Prevalence of epilepsy and seizures in the Navajo Nation 1998-2002
  43. Disparities in epilepsy: Report of a systematic review by the North American Commission of the International League Against Epilepsy
  44. Underlying cause of death in incident unprovoked seizures in the urban community of Northern Manhattan, New York City
  45. Antiepileptic drug use in women of childbearing age
  46. Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): I. Obstetrical complications and change in seizure frequency
  47. Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes
  48. Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): III. Vitamin K, folic acid, blood levels, and breast-feeding
  49. Practice Parameter update: Management issues for women with epilepsy--Focus on pregnancy (an evidence-based review): Obstetrical complications and change in seizure frequency: Report of the Quality Standards Subcommittee and Therapeutics and Technology...
  50. Practice Parameter update: Management issues for women with epilepsy--Focus on pregnancy (an evidence-based review): Teratogenesis and perinatal outcomes: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommit...
  51. Practice Parameter update: Management issues for women with epilepsy--Focus on pregnancy (an evidence-based review): Vitamin K, folic acid, blood levels, and breastfeeding: Report of the Quality Standards Subcommittee and Therapeutics and Technology As...
  52. PRACTICE PARAMETER: ASSESSING PATIENTS IN A NEUROLOGY PRACTICE FOR RISK OF FALLS (AN EVIDENCE-BASED REVIEW): REPORT OF THE QUALITY STANDARDS SUBCOMMITTEE OF THE AMERICAN ACADEMY OF NEUROLOGY
  53. Prevalence of self-reported epilepsy, health care access, and health behaviors among adults in South Carolina
  54. Estimating the incidence of first unprovoked seizure and newly diagnosed epilepsy in the low-income urban community of Northern Manhattan, New York City
  55. Practice Parameter: Assessing patients in a neurology practice for risk of falls (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology
  56. Prevalence of self-reported epilepsy in a multiracial and multiethnic community in New York City
  57. Prevalence of Active Epilepsy and Health-Related Quality of Life among Adults with Self-Reported Epilepsy in California: California Health Interview Survey, 2003
  58. HOW COMMON ARE THE "COMMON" NEUROLOGIC DISORDERS?
  59. Neurologic Disorders More Common Than Thought
  60. How common are the "common" neurologic disorders?
  61. Prevalence of Self-Reported Epilepsy or Seizure Disorder and Its Associations with Self-Reported Depression and Anxiety: Results from the 2004 Healthstyles Survey
  62. Comment on Epileptic Seizures and Epilepsy: Definitions Proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)
  63. Psychological Distress, Comorbidities, and Health Behaviors among U.S. Adults with Seizures: Results from the 2002 National Health Interview Survey
  64. Temporal and geographic variation in United States motor neuron disease mortality, 1969-1998
  65. Developing a Computer Algorithm to Identify Epilepsy Cases in Managed Care Organizations
  66. Estimating Prevalence, Incidence, and Disease-related Mortality for Patients with Epilepsy in Managed Care Organizations
  67. Developing a measure to assess attitudes toward epilepsy in the US population
  68. Prevalence of epilepsy and health status of adults with epilepsy in Georgia and Tennessee: Behavioral Risk Factor Surveillance System, 2002
  69. Estimating Nonfatal Traumatic Brain Injury Hospitalizations Using an Urban/Rural Index
  70. Practice parameter for electrodiagnostic studies in carpal tunnel syndrome: Summary statement
  71. Emergency department visits associated with traumatic brain injury: United States, 1995–1996
  72. Traumatic Brain Injury in the United States: A Public Health Perspective
  73. Trends in Hospitalization Associated With Traumatic Brain Injury
  74. Rehabilitation of Persons With Traumatic Brain Injury
  75. The Epidemiology of Sports-Related Traumatic Brain Injuries in the United States: Recent Developments
  76. Letter to the Editor
  77. Incidence of mild and moderate brain injury in the United States, 1991
  78. Monitoring the Impact of Traumatic Brain Injury: A Review and Update
  79. Risk factors and mechanisms of occurrence in motor vehicle-related spinal cord injuries: Utah
  80. Surveillance of spinal cord injuries in Utah, USA
  81. A COMMUNITY-WIDE OUTBREAK OF HEPATITIS A IN A RELIGIOUS COMMUNITY: IMPACT OF MASS ADMINISTRATION OF IMMUNE GLOBULIN
  82. Risk of Multiple Sclerosis Exacerbation During Pregnancy and Breast-feeding
  83. EMG and histochemical findings in neurogenic atrophy with electrode localisation.
  84. Clinical phenomena and their correlation to angiographic findings in cerebrovascular disease.
  85. The angiographic ocular choroidal crescent: Distortion with intraorbital and remote intracranial pathology